Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-26 · accession 0001055726-22-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-01 | 2022-02-26 | INO | Shea Jacqueline Elizabeth | COO | F - Tax | $3.22 | -10.8K | 33.4K | -24% | -$34.7K |
| D | 2022-03-01 | 2022-02-26 | INO | Shea Jacqueline Elizabeth | COO | M - OptEx | — | +22.5K | 44.1K | +104% | — |
| DM | 2022-03-01 | 2022-02-26 | INO | Shea Jacqueline Elizabeth | COO | A - Grant | $0.00 | +493.0K | 210.7K | New | $0 |
| D | 2022-03-01 | 2022-02-26 | INO | Shea Jacqueline Elizabeth | COO | M - OptEx | $0.00 | -22.5K | 45.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-26 | F | D | 10,764 | $3.22 | 33,373 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-26 | M | A | 22,545 | — | 44,137 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 3 | Derivative | Common Stock Option | 2022-02-26 | A | A | 282,300 | $0.00 | 282,300 | D | $3.22 · 2022-02-26 to 2032-02-26 | 282,300 Common Stock | (F3) The vesting schedule for the 282,300 options is as follows: 70,575 shares vested on February 26, 2022; 70,575 shares will vest on February 26, 2023; 70,575 shares will vest on February 26, 2024; 70,575 shares will vest on February 26, 2025. |
| 4 | Derivative | Restricted Stock Unit | 2022-02-26 | M | D | 22,545 | $0.00 | 45,088 | D | — · — to — | 22,545 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 5 | Derivative | Restricted Stock Unit | 2022-02-26 | A | A | 210,700 | $0.00 | 210,700 | D | — · — to — | 210,700 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 210,700 restricted stock units is as follows: 70,234 shares will vest on February 26, 2023; 70,233 shares will vest on February 26, 2024; 70,233 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |